GO:0030731 guanidinoacetate N-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030731 describes the enzymatic activity that converts guanidinoacetate to creatine using S-adenosyl-L-methionine as a methyl donor.
• This activity is essential for creatine biosynthesis and energy homeostasis in tissues with high energy demand, such as muscle and brain.
• Loss of guanidinoacetate N-methyltransferase (GAMT) function causes guanidinoacetate methyltransferase deficiency, a creatine deficiency syndrome with neurological symptoms.
• GAMT activity can be regulated by redox state, as recombinant rat liver GAMT is reversibly inactivated by glutathione disulfide.
• GAMT expression and activity vary across tissues and cultured cells, with high levels in liver and pancreas.
• Emerging evidence links GAMT to cancer progression, including pancreatic cancer, through circRNA-CGNL1-mediated regulation.
Description
Guanidinoacetate N-methyltransferase activity (GO:0030731) is a molecular function that catalyzes the final step of creatine biosynthesis: the methylation of guanidinoacetate to form creatine, using S-adenosyl-L-methionine (SAM) as the methyl donor. This reaction is critical for maintaining cellular energy stores, particularly in tissues with high and fluctuating energy demands such as skeletal muscle and brain. The enzyme responsible, GAMT, is expressed in various tissues, and its activity is tightly regulated to meet metabolic needs. Researchers study GO:0030731 to understand creatine metabolism, energy homeostasis, and the pathophysiology of creatine deficiency syndromes. Mutations in the GAMT gene lead to guanidinoacetate methyltransferase deficiency, an inherited disorder characterized by developmental delay, seizures, and movement disorders. Beyond rare diseases, GAMT activity has been implicated in cancer biology, where it may influence apoptosis and tumor progression. This article provides a comprehensive overview of GO:0030731, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and experimental approaches for studying this activity. The content is based on authoritative QuickGO data and verified PubMed literature, ensuring accuracy for researchers and AI-driven knowledge retrieval.
guanidinoacetate N-methyltransferase activity At A Glance
| GO ID | GO:0030731 |
|---|---|
| GO term | guanidinoacetate N-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | GA methylpherase activity; guanidinoacetate methyltransferase activity; guanidinoacetate transmethylase activity; guanidoacetate methyltransferase activity; methionine-guanidinoacetic transmethylase activity; S-adenosyl-L-methionine:N-guanidinoacetate methyltransferase activity |
| Major function | Catalyzes the final step of creatine biosynthesis by methylating guanidinoacetate to creatine. |
| Reaction | S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine + creatine + H+. |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor. |
| Tissue distribution | Expressed in liver, pancreas, and other tissues; activity detected in cultured cells. |
| Disease relevance | Deficiency causes GAMT deficiency, a creatine deficiency syndrome. |
What Is GO:0030731?
Guanidinoacetate N-methyltransferase activity (GO:0030731) is defined as the catalysis of the reaction: S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine + creatine + H+. In other words, it is the enzyme activity that transfers a methyl group from SAM to guanidinoacetate, producing creatine and S-adenosyl-L-homocysteine.
Why Is guanidinoacetate N-methyltransferase activity Important in Cell Biology?
Guanidinoacetate N-methyltransferase activity is essential for creatine biosynthesis, which is crucial for ATP regeneration in tissues with high energy demands, such as muscle and brain. Disruption of this activity leads to guanidinoacetate methyltransferase deficiency, a neurometabolic disorder with severe clinical manifestations. Additionally, GAMT activity is subject to redox regulation, highlighting its sensitivity to cellular oxidative state. Understanding this activity is therefore important for metabolic research, neurobiology, and cancer biology.
• Critical for creatine biosynthesis and energy homeostasis.
• Deficiency causes GAMT deficiency, a creatine deficiency syndrome with neurological symptoms.
• Creatine supplementation is a therapeutic strategy for GAMT deficiency and other conditions.
• GAMT knockout mice show age-dependent cardiac dysfunction, linking GAMT to heart physiology.
• GAMT is a target for small-molecule methyltransferase profiling.
• GAMT activity is regulated by redox state via glutathione disulfide.
• GAMT expression varies across tissues, with high activity in liver and pancreas.
• Mild GAMT deficiency affects brain cell development.
• GAMT is implicated in pancreatic cancer progression through circRNA-CGNL1 regulation.
• GAMT activity can be measured in cultured cells for metabolic studies.
What Happens During guanidinoacetate N-methyltransferase activity?
Substrate Binding and Methyl Transfer
In simple terms: The enzyme grabs guanidinoacetate and a methyl donor, then moves a methyl group onto guanidinoacetate.
Guanidinoacetate N-methyltransferase binds its substrates, guanidinoacetate and S-adenosyl-L-methionine (SAM), in an ordered manner. The enzyme catalyzes the transfer of a methyl group from SAM to the nitrogen atom of guanidinoacetate, forming creatine and S-adenosyl-L-homocysteine (SAH). This reaction is the final step in creatine biosynthesis.
Product Release and Creatine Utilization
In simple terms: After creatine is made, it is released and used by cells for energy storage.
Following methyl transfer, creatine and SAH are released from the active site. Creatine is then phosphorylated by creatine kinase to phosphocreatine, which serves as a rapid energy buffer in tissues such as muscle and brain. The byproduct SAH is a potent inhibitor of methyltransferases and is metabolized to homocysteine and adenosine.
Redox Regulation of Enzyme Activity
In simple terms: The enzyme can be turned off and on by changes in the cell's oxidative state.
Recombinant rat liver GAMT is reversibly inactivated by glutathione disulfide (GSSG), indicating that the enzyme's activity is modulated by the cellular redox environment. This redox sensitivity may link creatine biosynthesis to oxidative stress conditions.
Tissue-Specific Expression and Activity
In simple terms: Different tissues have different amounts of this enzyme, matching their energy needs.
GAMT activity is detected in various tissues and cultured cells, with high levels in liver and pancreas. This tissue-specific distribution reflects the demand for creatine synthesis and energy metabolism in different organs.
Key Genes Involved in GO:0030731 guanidinoacetate N-methyltransferase activity
The following genes and proteins are directly or indirectly involved in guanidinoacetate N-methyltransferase activity and its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GAMT | Encodes guanidinoacetate N-methyltransferase, the enzyme catalyzing the final step of creatine biosynthesis. | Mutations cause GAMT deficiency; target for metabolic and neurological studies. |
| GATM | Encodes glycine amidinotransferase, which produces guanidinoacetate, the substrate for GAMT. | Rate-limiting step in creatine biosynthesis; studied in creatine deficiency disorders. |
| SLC6A8 | Creatine transporter; imports creatine into cells. | Defects cause creatine transporter deficiency; relevant to creatine metabolism. |
| CKB | Creatine kinase B; phosphorylates creatine to phosphocreatine. | Energy buffering in brain; linked to GAMT knockout phenotypes. |
| CKM | Creatine kinase M; muscle-specific isoform. | Cardiac and skeletal muscle energy metabolism; affected in GAMT KO mice. |
| MAT1A | Methionine adenosyltransferase; synthesizes SAM, the methyl donor for GAMT. | Provides SAM for methylation reactions; studied in liver metabolism. |
| AHCY | S-adenosylhomocysteine hydrolase; metabolizes SAH produced by GAMT. | Regulates methylation potential; relevant to GAMT activity. |
| GNMT | Glycine N-methyltransferase; another SAM-dependent methyltransferase. | Model for methyltransferase profiling; potential off-target in inhibitor studies. |
| NUDT4 | Nudix hydrolase; involved in circRNA-CGNL1-mediated regulation of GAMT in pancreatic cancer. | Modulates GAMT expression; cancer research target. |
| HDAC4 | Histone deacetylase; part of circRNA-CGNL1/NUDT4/HDAC4/RUNX2/GAMT axis. | Regulates GAMT transcription; cancer progression studies. |
| RUNX2 | Transcription factor; regulates GAMT expression in pancreatic cancer. | Transcription factor binding to GAMT promoter; cancer biology. |
| CGNL1 | Gene hosting circRNA-CGNL1; regulates GAMT via NUDT4-HDAC4-RUNX2 axis. | CircRNA involved in pancreatic cancer progression. |
| GSSG | Glutathione disulfide; reversibly inactivates GAMT. | Redox regulation of GAMT activity. |
| GSH | Glutathione; reduces GSSG, reactivating GAMT. | Redox homeostasis; affects GAMT activity. |
| SAM | S-adenosyl-L-methionine; methyl donor for GAMT. | Cofactor; central to methylation reactions. |
| SAH | S-adenosyl-L-homocysteine; product and inhibitor of GAMT. | Feedback inhibition; methylation balance. |
| Creatine | Product of GAMT; energy buffer. | Supplementation therapy for GAMT deficiency. |
| Guanidinoacetate | Substrate of GAMT; elevated in GAMT deficiency. | Biomarker for GAMT deficiency; neurotoxic at high levels. |
How Is guanidinoacetate N-methyltransferase activity Regulated?
Guanidinoacetate N-methyltransferase activity is regulated at multiple levels. The enzyme is reversibly inactivated by glutathione disulfide (GSSG), linking its activity to the cellular redox state. Additionally, GAMT expression can be modulated by transcription factors such as RUNX2, as part of a circRNA-CGNL1/NUDT4/HDAC4/RUNX2 axis in pancreatic cancer. Tissue-specific expression patterns also contribute to regulation, with high activity in liver and pancreas.
guanidinoacetate N-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GAMT | GAMT deficiency (creatine deficiency syndrome) | GAMT knockout mice; patient-derived fibroblasts |
| GAMT | Pancreatic cancer progression | Pancreatic cancer cell lines with circRNA-CGNL1 modulation |
| GAMT | Cardiac dysfunction | GAMT knockout mice |
| GAMT | Brain cell development | Neuronal cultures from GAMT-deficient models |
| GAMT | Creatine metabolism disorders | Induced pluripotent stem cells (iPSCs) with GAMT mutations |
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)
GAMT deficiency is an autosomal recessive disorder caused by mutations in the GAMT gene, leading to reduced or absent guanidinoacetate N-methyltransferase activity. This results in creatine depletion and accumulation of guanidinoacetate, causing developmental delay, seizures, and movement disorders. Creatine supplementation is a primary treatment, often combined with dietary restrictions.
Cardiac Dysfunction in GAMT Knockout Mice
Age-dependent decline in cardiac function has been observed in guanidinoacetate N-methyltransferase knockout mice, highlighting the importance of GAMT in heart physiology. These mice exhibit impaired energy metabolism, suggesting that GAMT activity is critical for cardiac function under stress.
GAMT in Pancreatic Cancer
A novel circRNA-CGNL1 regulates pancreatic cancer progression via a NUDT4-HDAC4-RUNX2-GAMT-mediated apoptosis pathway. GAMT expression is modulated in this axis, and its dysregulation may contribute to tumorigenesis, suggesting GAMT as a potential therapeutic target.
Mild GAMT Deficiency and Brain Development
Mild guanidinoacetate increase under partial GAMT deficiency strongly affects brain cell development, indicating that even subtle reductions in enzyme activity can have neurodevelopmental consequences. This underscores the importance of early diagnosis and intervention.
From guanidinoacetate N-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of GAMT activity? | GAMT knockout mice |
| How do specific point mutations affect GAMT stability or activity? | Point-mutation knock-in cell lines (e.g., HEK293T) |
| Can wild-type GAMT rescue metabolic defects? | Knock-in of wild-type GAMT in GAMT-null cells |
| Where is GAMT localized in cells? | Tagged knock-in of GAMT with fluorescent protein |
| What happens when GAMT is overexpressed? | Overexpression cell lines (e.g., HepG2) |
| How does GAMT deficiency affect brain development? | Patient-derived iPSCs differentiated into neurons |
How to Study the guanidinoacetate N-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiochemical assay | Conversion of radiolabeled guanidinoacetate to creatine | Enzyme kinetics and inhibitor screening |
| LC-MS/MS | Creatine, guanidinoacetate, SAM, SAH levels | Metabolic profiling in tissues and cells |
| RNA-seq | GAMT mRNA expression | Tissue-specific expression and regulation |
| Western blot | GAMT protein levels | Validation of knockout or overexpression |
| CRISPR knockout screen | Genes affecting GAMT activity | Discovery of regulators |
| Immunofluorescence | Subcellular localization of GAMT | Tagged knock-in studies |
| CircRNA profiling | circRNA-CGNL1 expression | Cancer progression studies |
| Enzyme-linked immunosorbent assay (ELISA) | GAMT protein concentration | High-throughput screening |
Enzymatic Activity Assays
Guanidinoacetate N-methyltransferase activity can be measured using radiochemical or mass spectrometry-based assays that detect the conversion of guanidinoacetate to creatine. These assays are used to quantify enzyme kinetics and screen for inhibitors.
Gene Expression Analysis
RNA-seq and qPCR can quantify GAMT mRNA levels across tissues and cell lines. This helps determine tissue-specific expression and regulation by transcription factors such as RUNX2.
Metabolite Profiling
Mass spectrometry-based metabolomics can measure creatine, guanidinoacetate, SAM, and SAH levels to assess GAMT activity in cells and tissues. This is particularly useful for diagnosing GAMT deficiency.
CRISPR-Based Genetic Screens
CRISPR knockout screens can identify genes that modulate GAMT activity or creatine metabolism. Such screens are valuable for discovering novel regulators and therapeutic targets.
How CRISPR Can Be Used to Study GO:0030731 guanidinoacetate N-methyltransferase activity
Knockout
CRISPR-Cas9 knockout of GAMT can create cell models to study the consequences of loss of guanidinoacetate N-methyltransferase activity. These models are useful for investigating creatine depletion, guanidinoacetate accumulation, and related metabolic pathways.
Point Mutation
Introducing specific point mutations into the GAMT gene via CRISPR can mimic patient mutations and help dissect the structure-function relationship of the enzyme. Such models are valuable for testing the impact of missense mutations on enzyme activity and stability.
Knock-in
Knock-in of tagged GAMT (e.g., GFP or FLAG) allows for real-time tracking of enzyme localization and interaction partners. This approach can also be used to rescue GAMT deficiency in patient-derived cells.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase GAMT levels to study the effects of enhanced creatine biosynthesis on cellular metabolism and stress responses.
How EDITGENE Supports guanidinoacetate N-methyltransferase activity Research
Researchers studying guanidinoacetate N-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in creatine metabolism, neurological disorders, or cancer. EDITGENE provides comprehensive CRISPR-based services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for guanidinoacetate N-methyltransferase activity research.
Frequently Asked Questions About guanidinoacetate N-methyltransferase activity
What is guanidinoacetate N-methyltransferase activity?
It is the enzyme activity that catalyzes the conversion of guanidinoacetate to creatine using S-adenosyl-L-methionine as a methyl donor, encoded by the GAMT gene.
What genes are involved in guanidinoacetate N-methyltransferase activity?
The primary gene is GAMT, but related genes include GATM, SLC6A8, CKB, and CKM, which are involved in creatine metabolism.
What diseases are associated with GAMT deficiency?
GAMT deficiency causes a creatine deficiency syndrome with developmental delay, seizures, and movement disorders.
How is guanidinoacetate N-methyltransferase activity regulated?
It is regulated by redox state via glutathione disulfide and by transcription factors such as RUNX2 in cancer.
What is the reaction catalyzed by GAMT?
S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine + creatine + H+.
Can creatine supplementation treat GAMT deficiency?
Yes, creatine supplementation is a primary therapy for GAMT deficiency, often combined with dietary restrictions.
What animal models exist for GAMT deficiency?
GAMT knockout mice are widely used and exhibit cardiac dysfunction and metabolic abnormalities.
How can I measure GAMT activity in the lab?
Enzymatic assays using radiolabeled substrates or mass spectrometry can quantify GAMT activity.
Is GAMT involved in cancer?
Yes, GAMT is implicated in pancreatic cancer progression through a circRNA-CGNL1-mediated pathway.
What cell models are available for studying GAMT?
Knockout, point-mutation, knock-in, and overexpression cell lines can be generated using CRISPR technology.
Conclusion
Guanidinoacetate N-methyltransferase activity (GO:0030731) is a critical enzymatic function in creatine biosynthesis, with profound implications for energy metabolism, neurodevelopment, and disease. Understanding its regulation and role in conditions such as GAMT deficiency and cancer is essential for developing targeted therapies. Advanced CRISPR-based models and analytical methods continue to illuminate the molecular mechanisms and therapeutic potential of this activity.
References
- 1. Konishi K et al.. 1991. Reversible inactivation of recombinant rat liver guanidinoacetate methyltransferase by glutathione disulfide.. Arch Biochem Biophys 289(1):90-6 PMID: 1898065
- 2. Gordon N. 2010. Guanidinoacetate methyltransferase deficiency (GAMT).. Brain Dev 32(2):79-81 PMID: 19289269
- 3. Evangeliou A et al.. 2009. Clinical applications of creatine supplementation on paediatrics.. Curr Pharm Biotechnol 10(7):683-90 PMID: 19751179
- 4. Aksentijević D et al.. 2019. Age-Dependent Decline in Cardiac Function in Guanidinoacetate-N-Methyltransferase Knockout Mice.. Front Physiol 10:1535 PMID: 32038270
- 5. Hanson QM et al.. 2023. Target Class Profiling of Small-Molecule Methyltransferases.. ACS Chem Biol 18(4):969-981 PMID: 36976909
- 6. Yuan H et al.. 2024. Role of a novel circRNA-CGNL1 in regulating pancreatic cancer progression via NUDT4-HDAC4-RUNX2-GAMT-mediated apoptosis.. Mol Cancer 23(1):27 PMID: 38297362
- 7. Hanna-El-Daher L et al.. 2015. Mild guanidinoacetate increase under partial guanidinoacetate methyltransferase deficiency strongly affects brain cell development.. Neurobiol Dis 79:14-27 PMID: 25896543
- 8. Daly MM. 1985. Guanidinoacetate methyltransferase activity in tissues and cultured cells.. Arch Biochem Biophys 236(2):576-84 PMID: 3970526
